As per NAVADHI Market Research, the global pharmaceutical industry [4] will we worth USD 1.57 trillion by 2023.
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. The company has a presence in approx. 100 countries worldwide. Amgen operates in one business segment: human therapeutics.
Amgen reported revenue of USD 23.747 billion for the FY 2018 which saw an increase of 3.93% compared to FY 2017. This revenue is expected to decrease by 3.57% and reach USD 22.90 billion by FY 2019 due to loss of patent and price erosion of key drugs. Amgen revenue grew at a CAGR of 4.92% during FY 2013 to FY 2018.
Amgen registered the highest revenue from the United States market at USD 18.358 billion which accounted for 77.31% of its total revenue in FY 2018.
•This report provides detailed information about Amgen Inc including value chain analysis, financial performance, business strategy, and SWOT analysis.
•The report identifies the growth drivers and inhibitors for the global pharmaceutical market.
•This report provides information about current and future trends for the global pharmaceutical market.
*If Applicable.
Links
[1] https://www.marketresearchreports.com/countries/global[2] https://www.marketresearchreports.com/pharma-healthcare[3] https://www.marketresearchreports.com/company-reports-pharma-healthcare[4] https://www.marketresearchreports.com/navadhi/global-pharmaceuticals-industry-analysis-and-trends-2023